汇金股份：2025年前三季度净利润约-5163万元

Group 1 - Company Hui Jin Co., Ltd. reported a revenue of approximately 113 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 29.52% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 51.63 million yuan, with basic earnings per share showing a loss of 0.0976 yuan [1] - As of the report date, the market capitalization of Hui Jin Co., Ltd. was 9.3 billion yuan [2] Group 2 - The Chinese innovative drug sector has seen overseas licensing sales reach 80 billion US dollars this year [2] - There is a notable contrast in the biopharmaceutical secondary market being active while the primary market is experiencing a cooling in fundraising [2]